青霉素皮肤试验作为抗菌药物管理举措
本文描述了一个社区健康系统开展的青霉素皮肤试验(PST)项目,旨在从抗菌药物管理角度评估其效果。在8个月内完成PST方案的36例患者中,全部结果阴性,其中27例直接因PST而将抗菌治疗转换为青霉素或头孢菌素。结论认为,在自报青霉素过敏的患者中,PST减少了碳青霉烯类、氨曲南、万古霉素等广谱药物的使用,并在转换患者样本中记录了药物成本下降。
要点
- 自报青霉素过敏者中仅约10%准确,错误过敏标签是抗菌药物管理的重要障碍。
- 36例完成PST方案的患者全部阴性,27例据此转换为青霉素或头孢菌素。
- PST减少了碳青霉烯类、氨曲南、万古霉素等广谱药物使用并降低药物成本。
核心结论
- 在自报青霉素过敏的患者中,PST减少了碳青霉烯类、氨曲南、万古霉素和其他广谱药物的使用。
- 在转换为青霉素或头孢菌素的患者样本中,记录了药物成本下降。
研究设计与样本
- 社区健康系统作为抗菌药物管理项目的一部分,启动了PST举措。
- PST项目采用标准化方案评估疑似青霉素过敏患者的高敏反应。
- 8个月期间共36例患者完成PST方案。
主要发现
- 完成PST方案的36例患者全部结果为阴性。
- 36例中有27例直接因PST而将抗菌治疗转换为青霉素或头孢菌素。
关键数值与推荐
- 自报青霉素过敏中仅约10%准确。
- 错误青霉素过敏可导致抗菌药物耐药增加、总医疗成本增加、住院时间延长及死亡率增加。
临床怎么用
- 对自报青霉素过敏患者实施标准化PST方案,以优化治疗、减少不良事件获取成本并最小化抗生素耐药发展。
- PST结果阴性后可将抗菌治疗转换为青霉素或头孢菌素,以减少广谱药物使用并降低药物成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: An initiative to determine the effects of penicillin skin testing (PST) from an antimicrobial stewardship perspective is described. SUMMARY: Penicillin allergy is one of the most frequently reported allergies; however, only about 10% of self-reports of penicillin allergy are accurate. Incorrect penicillin allergies are therefore a significant barrier to antimicrobial stewardship, with important clinical and economic implications, including increased antimicrobial resistance, an increased overall cost of care, increased length of stay, and, ultimately, increased mortality. As part of its antimicrobial stewardship program, a community health system launched a PST initiative in order to optimize therapy, reduce adverse events acquisition costs, and minimize development of antibiotic resistance. The PST program involves the use of a standardized protocol for the assessment of hypersensitivity to penicillin in patients with suspected penicillin allergy. Among 36 patients who completed the PST protocol during an eight-month period, all had a negative result; in 27 of those patients, a conversion of antimicrobial therapy to a penicillin or cephalosporin was implemented as a direct result of PST. CONCLUSION: In patients with a self-reported penicillin allergy, PST led to a reduction in the use of carbapenems, aztreonam, vancomycin, and other broad-spectrum agents within a health system. A decrease in drug costs was documented in a sample of patients switched to a penicillin or a cephalosporin after PST.
引用
- Jones BM, Bland CM. Penicillin skin testing as an antimicrobial stewardship initiative. Am J Health Syst Pharm. 2017. PMID: 28179249. doi:10.2146/ajhp160233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。